Ernest Stephen Sirimanne

Title: Ernest Stephen Sirimanne: Innovator in Neuropathy Treatment

Introduction

Ernest Stephen Sirimanne is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of medicine, particularly in the treatment of peripheral neuropathy. His innovative approach has led to the development of a unique compound that holds promise for patients suffering from this condition.

Latest Patents

Sirimanne holds a patent for "Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy." This invention provides methods for the therapeutic use of cyclic G-2-allylProline (cG-2-allylP) to treat various forms of peripheral neuropathies, including toxin-induced and diabetic peripheral neuropathy. The patent outlines the manufacture of medicaments, including tablets, capsules, and injectable solutions that are effective for treating these conditions. He has 1 patent to his name.

Career Highlights

Throughout his career, Sirimanne has focused on developing innovative solutions for medical challenges. His work has been instrumental in advancing treatment options for patients with peripheral neuropathy. His dedication to research and development has positioned him as a key figure in the medical community.

Collaborations

Sirimanne has collaborated with esteemed colleagues, including Mike John Bickerdike and Margaret Anne Brimble. These partnerships have enhanced his research efforts and contributed to the success of his inventions.

Conclusion

Ernest Stephen Sirimanne is a pioneering inventor whose work in neuropathy treatment showcases the potential of innovative medical solutions. His contributions are paving the way for improved therapies for patients suffering from peripheral neuropathy.